Beclometasone/formoterol/glycopyrronium pMDI for severe asthma

Description

In this Product Explainer, Respiratory Physician Dr Andrew Scroop explains the role of beclometasone/ formoterol/ glycopyrronium pressurised metered dose inhalers (pMDIs) for maintenance treatment in adult patients with uncontrolled asthma despite treatment with an ICS and a LABA with a history of exacerbations (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Sushil Pant

Dr Sushil Pant

Acutely Painful Shoulder – Assessment and Management in GP

Dr Richard Phoon

Dr Richard Phoon

Chronic Kidney Disease – Delay Progression and Prevent Dialysis

Prof Rodney Baber AM

Prof Rodney Baber AM

Understand & Explain the Risks & Side Effects of MHT

Prof Peter Richmond

Prof Peter Richmond

Invasive Pneumococcal Disease – What GPs Need to Know

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Andrew Scroop

expert

Dr Andrew Scroop

Respiratory Physician; Founding Director of Respiratory Consultants, St Andrews Medical Centre

Date published: 24 January 2025